APA to sponsor Medication Assisted Treatment (MAT) Train the Trainer (TTT) Program
The 2019 Buprenorphine and Medication Assisted Treatment (MAT) Train the Trainer (TTT) Program application is currently open for submission. The Buprenorphine and MAT TTT Program, hosted in partnership by the American Psychiatric Association (APA) and Providers Clinical Support System (PCSS), is a two-day program hosted in Washington, DC that offers an in-depth training to DEA-X waivered psychiatrists who are currently prescribing buprenorphine to patients and are interested in serving as a regional buprenorphine trainer. The program aims to expand the network of local buprenorphine trainers nation-wide, increase the number of buprenorphine trainings, and expand the number of buprenorphine-waivered physicians to increase access to MAT.
This year’s program will be held from June 9-10, 2019 at the APA main office in Washington, DC. APA will provide travel and accommodations for all TTT program participants in accordance with APA travel policies, and 8 Continuing Medical Education (CME) credits will be offered for the completion of the program. All applicants are required to submit a letter of support from their respective district branch outlining plans for their first training and how they plan to secure funding. The deadline to apply for the TTT program is Friday, April 26, 2019.
There is no fee to apply or participate in the TTT program. Visit the Buprenorphine and MAT TTT program website to learn more about eligibility and application requirements. Please contact Rachel Trusty at email@example.com for additional questions.
Rachel Trusty, MS, MHS
Program Manager | Division of Education
American Psychiatric Association